21 results
8-K
EX-99.1
3c6 pa4dhta96h
9 Aug 22
Results of Operations and Financial Condition
7:36am
8-K
EX-99.2
uoqu6xv
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
8-K
EX-99.1
gb3e t8gh3
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
10-K
25htu723ilge 1g
1 Mar 22
Annual report
4:07pm
8-K
EX-99.1
jngyra
1 Mar 22
Xilio Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results
8:00am
8-K
EX-99.1
2ew ao0heokh49l
6 Jan 22
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
7:45am
10-Q
ne7ti
2 Dec 21
Quarterly report
4:15pm
8-K
EX-99.1
hlkthg1dz44
2 Dec 21
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results
8:00am
424B4
wft3kdbhbn6cxz77jjh1
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
1iq2z49pvn d3q
18 Oct 21
IPO registration (amended)
6:04am
S-1
ljlnkk aeox1ofl
1 Oct 21
IPO registration
4:49pm
DRS/A
u86x6b vr05legjml
14 Sep 21
Draft registration statement (amended)
12:00am